🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Uğur Eskiocak

Therapeutics Clinical Research

ORCID: 0000-0003-3785-5275
Biochemistry, Genetics and Molecular BiologyMedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer.

19 citations

Miso Park, Magali Pederzoli-Ribeil, Uğur Eskiocak, Parker Johnson, Wilson Guzman +14 more

18 citations

Andrew R. Jamieson, Erik S. Welf, Andres Nevarez, Justin Cillay, Uğur Eskiocak +3 more

158 citations

Jessica A. Mine, Subir Biswas, Ricardo A. Chaurio, Alfredo Perales‐Puchalt, Carmen M. Anadon +22 more

91 citations

Zhaohuan Zhang, Tomoyuki Mashimo, Bo Shen, James O. Nyagilo, Hao Wang +16 more

99 citations

Andrew R. Jamieson, Erik S. Welf, Andres Nevarez, Justin Cillay, Uğur Eskiocak +3 more